| Large soluble oligomers of amyloid β-protein from Alzheimer brain are far less neuroactive than the smaller oligomers to which they dissociate T Yang, S Li, H Xu, DM Walsh, DJ Selkoe Journal of Neuroscience 37 (1), 152-163, 2017 | 354 | 2017 |
| Soluble Aβ oligomers impair hippocampal LTP by disrupting glutamatergic/GABAergic balance M Lei, H Xu, Z Li, Z Wang, TT O'Malley, D Zhang, DM Walsh, P Xu, ... Neurobiology of disease 85, 111-121, 2016 | 153 | 2016 |
| Environmental enrichment potently prevents microglia-mediated neuroinflammation by human amyloid β-protein oligomers H Xu, E Gelyana, M Rajsombath, T Yang, S Li, D Selkoe Journal of Neuroscience 36 (35), 9041-9056, 2016 | 114 | 2016 |
| Choroid plexus NKCC1 mediates cerebrospinal fluid clearance during mouse early postnatal development H Xu, RM Fame, C Sadegh, J Sutin, C Naranjo, D Syau, J Cui, FB Shipley, ... Nature communications 12 (1), 447, 2021 | 82 | 2021 |
| Tracking calcium dynamics and immune surveillance at the choroid plexus blood-cerebrospinal fluid interface FB Shipley, N Dani, H Xu, C Deister, J Cui, JP Head, C Sadegh, RM Fame, ... Neuron 108 (4), 623-639. e10, 2020 | 78 | 2020 |
| Enriched environment enhances β‐adrenergic signaling to prevent microglia inflammation by amyloid‐β H Xu, MM Rajsombath, P Weikop, DJ Selkoe EMBO molecular medicine 10 (9), e8931, 2018 | 64 | 2018 |
| Macrophages on the margin: choroid plexus immune responses J Cui, H Xu, MK Lehtinen Trends in neurosciences 44 (11), 864-875, 2021 | 52 | 2021 |
| Disruption of the ATP/adenosine balance in CD39−/− mice is associated with handling‐induced seizures AJ Lanser, RM Rezende, S Rubino, PJ Lorello, DJ Donnelly, H Xu, ... Immunology 152 (4), 589-601, 2017 | 31 | 2017 |
| Choroid plexus-targeted NKCC1 overexpression to treat post-hemorrhagic hydrocephalus C Sadegh, H Xu, J Sutin, B Fatou, S Gupta, A Pragana, M Taylor, ... Neuron 111 (10), 1591-1608. e4, 2023 | 23 | 2023 |
| A self-microemulsifying formulation of oxyresveratrol prevents amyloid beta protein-induced neurodegeneration in mice Y Sangsen, T Sooksawate, K Likhitwitayawuid, B Sritularak, ... Planta Medica 84 (11), 820-828, 2018 | 18 | 2018 |
| Defining diurnal fluctuations in mouse choroid plexus and CSF at high molecular, spatial, and temporal resolution RM Fame, PN Kalugin, B Petrova, H Xu, PA Soden, FB Shipley, N Dani, ... Nature communications 14 (1), 3720, 2023 | 11 | 2023 |
| Choroid plexus NKCC1 mediates cerebrospinal fluid clearance during mouse early postnatal development. Nat. Commun. 12, 447 H Xu, RM Fame, C Sadegh, J Sutin, C Naranjo, S Della, J Cui, FB Shipley, ... | 8 | 2021 |
| Structures and absolute configurations of phomalones from the coral-associated fungus Parengyodontium album sp. SCSIO 40430 L Wang, Y Huang, L Zhang, Z Liu, W Liu, H Xu, Q Zhang, H Zhang, Y Yan, ... Organic & Biomolecular Chemistry 19 (27), 6030-6037, 2021 | 8 | 2021 |
| Age-appropriate potassium clearance from perinatal cerebrospinal fluid depends on choroid plexus NKCC1 RM Fame, H Xu, A Pragana, M Lehtinen Fluids and Barriers of the CNS 20 (1), 45, 2023 | 4 | 2023 |
| Choroid plexus organoids: Harnessing CSF gatekeepers for brain therapeutics H Xu, MK Lehtinen Cell Stem Cell 27 (2), 191-192, 2020 | 4 | 2020 |
| A collaboration between immune cells and the choroid plexus epithelium in brain inflammation H Xu, P Lotfy, S Gelb, A Pragana, C Hehnly, FB Shipley, ME Zawadzki, ... bioRxiv, 2023.08. 07.552298, 2023 | 3 | 2023 |
| Enriched environment enhances β‐adrenergic signaling to prevent microglia inflammation by amyloid‐β H Xu, MM Rajsombath, P Weikop, DJ Selkoe EMBO Molecular Medicine 15 (1), e17061, 2023 | 2 | 2023 |
| Cerebrospinal fluid magnetic resonance imaging: improving early diagnosis of autism and other neurodevelopmental conditions H Xu, MK Lehtinen Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 5 (7), 635-637, 2020 | 2 | 2020 |
| SCO-spondin knockout mice exhibit small brain ventricles and mild spine deformation H Xu, GP Dugué, Y Cantaut-Belarif, FX Lejeune, S Gupta, C Wyart, ... Fluids and Barriers of the CNS 20 (1), 89, 2023 | 1 | 2023 |
| Compositions and methods for treating cerebrospinal fluid disorders MK Lehtinen, C SADEGH, H Xu US Patent App. 18/360,505, 2024 | | 2024 |
